In an animal model of glioblastoma, CSF-1R blockade demonstrated significant potential to reduce tumor growth, suggesting that CSF-1R inhibitors can block TAM-mediated immunosuppression and make tumor cells more susceptible to chemotherapeutics (120). The gene discussed is CSF1R; the disease is glioblastoma.